1-11 of 11
Rajendra Damle
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pseudo-Progression Among Patients with Follicular Lymphoma Treated with Ibrutinib in the Phase 2 DAWN Study

Gilles A. Salles, Judith Trotman, MB ChB, Michael Lill, MD BS, Bruce Cheson, MD, Stephen J. Schuster, MD, Jing-Zhou Hou, John A Radford, MB ChB, MRCP, MD FRCP, Andrew Spencer, Michael Schaffer, PhD, Rajendra Damle, PhD, Gary J. Gartenberg, MD, Jessica Vermeulen, MD PhD, Sriram Balasubramanian, PhD, Sanjay Deshpande, MD, Dolores Caballero, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2980.
https://doi.org/10.1182/blood.V128.22.2980.2980
Published: 2016
Journal Articles

Early Changes in Circulating T-Cell Immune Profiles in Patients with Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Data from the Phase 3, Double-Blind HELIOS Trial

Rajendra Damle, PhD, Michael Schaffer, PhD, Shalini Chaturvedi, PhD, Charles Phelps, MSc, Regina Aquino, MSc, Michelle Mahler, MD, Mariya Salman, PhD, Angela Howes, PhD, Javier Loscertales, MD PhD, Marek Trneny, MD, Dina Ben Yehuda, MD, Alexander Pristupa, MD, Asher A. Chanan-Khan, MD, Sriram Balasubramanian, PhD
Journal: Blood
Blood (2016) 128 (22): 4397.
https://doi.org/10.1182/blood.V128.22.4397.4397
Published: 2016
Journal Articles

Impact of High Risk Prognostic Parameters and Addition of Ibrutinib to Bendamustine/Rituximab (BR) on Outcomes for Patients with Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) from the Phase 3 Double-Blind HELIOS Trial

Asher Chanan-Khan, MD, Paula Cramer, MD, Graeme Fraser, MDFRCPC, Rodrigo Santucci Silva, MD, Sebastian Grosicki, MD PhD, Aleksander Pristupa, MD, Marie Sarah Dilhuydy, MD, Andre Goy, MD, Anthony R. Mato, MD MSCE, Rajendra Damle, PhD, Charles Phelps, MS, Michelle Mahler, MD, Mariya Salman, PhD, Michael Schaffer, PhD, Angela Howes, PhD, Sriram Balasubramanian, PhD
Journal: Blood
Blood (2015) 126 (23): 1732.
https://doi.org/10.1182/blood.V126.23.1732.1732
Published: 2015
Journal Articles

CD38 and chronic lymphocytic leukemia: a decade later

Fabio Malavasi, Silvia Deaglio, Rajendra Damle, Giovanna Cutrona, Manlio Ferrarini, Nicholas Chiorazzi
Journal: Blood
Blood (2011) 118 (13): 3470–3478.
https://doi.org/10.1182/blood-2011-06-275610
Published: 2011
Journal Articles

Efficiency of BCR: Anti-BCR Interaction Dictates Cellular Outcomes of Signaling in Chronic Lymphocytic Leukemia Cells

Rajendra Damle, Sonal Temburni, Tara Schaaf, Santanu Paul, Patricia Mongini, Steven L. Allen, Matthew Kaufman, Kanti Rai, Nicholas Chiorazzi
Journal: Blood
Blood (2008) 112 (11): 3122.
https://doi.org/10.1182/blood.V112.11.3122.3122
Published: 2008
Journal Articles

Different Expression of FcgammaRIIb in Chronic Lymphocytic Leukemia and Human Normal B Lymphocytes

Carol Moreno, Rajendra Damle, Sonia Jansa, Gerardo Ferrer, Pau Abrisqueta, Aina Pons, Marta Aymerich, Ezio Bonvini, Joshua Trott, Emili Montserrat, Nicholas Chiorazzi
Journal: Blood
Blood (2008) 112 (11): 3134.
https://doi.org/10.1182/blood.V112.11.3134.3134
Published: 2008
Journal Articles

Improved Prognosis of Chronic Lymphocytic Leukemia (CLL) Patients with Increased IgVH Mutations May Reflect Greater Alteration of the B-Cell Receptor (BCR) Binding Site

Matthew Kaufman, MD, Xiao Yan, MD, PhD, Rajendra Damle, PhD, Nina Kohn, MS, Martin Lesser, PhD, Nancy Driscoll, R-PA, Christina Johnson, R-PA, Jahan Aghalar, Yehuda Lebowicz, MD, Kanti Rai, MD, Nicholas Chiorazzi, MD
Journal: Blood
Blood (2008) 112 (11): 3152.
https://doi.org/10.1182/blood.V112.11.3152.3152
Published: 2008
Journal Articles

High-Resolution Array-Based Comparative Genome Hybridization (CGH) Identifies Novel and Recurrent Regions in CLL.

Vladimir Grubor, PhD, Alex Krasnitz, PhD, Jennifer E. Troge, Jennifer L. Meth, B. Lakshmi, PhD, Jude T. Kendall, Boris Yamrom, PhD, Garrick Alex, Deepa Pai, Nicholas Navin, Lisa A. Hufnagel, Yoon-ha Lee, PhD, Kerry Cook, Steven L. Allen, MD, Kanti R. Rai, MD, Rajendra Damle, PhD, Carlo Calissano, PhD, Nicholas Chiorazzi, MD, Michael H Wigler, PhD, Diane Esposito, PhD
Journal: Blood
Blood (2008) 112 (11): 2058.
https://doi.org/10.1182/blood.V112.11.2058.2058
Published: 2008
Journal Articles

In Vivo Labeling of Dividing Chronic Lymphocytic Leukemia B Cells Suggests That CXCR4 and CD5 Define the Clonal Subfraction That Recently Proliferatead and Emigrated from a Solid Tissue

Carlo calissano, MD, Rajendra Damle, PhD, Gregory Hayes, PhD, Elisabeth J Murphy, MD, PhD, Marc Hellerstein, MD, PhD, Barbara Sherry, PhD, Matthew S Kaufman, MD, Steven L Allen, MD, Kanti Rai, MD, Nicholas Chiorazzi, MD
Journal: Blood
Blood (2008) 112 (11): 358.
https://doi.org/10.1182/blood.V112.11.358.358
Published: 2008
Journal Articles

Surprising Lack of Correlation between CD38 and Time to First Treatment in Chronic Lympocytic Leukemia.

Matthew S. Kaufman, MD, Rajendra Damle, PhD, Nina Kohn, MA, Christina Johnson, RPA-C, Nancy Driscoll, RPA-C, Angelica Caramanica, RPA-C, Yehuda Lebowicz, MD, Kai Tsao, MD, Nicholas Chiorazzi, MD, Kanti Rai, MD
Journal: Blood
Blood (2007) 110 (11): 2058.
https://doi.org/10.1182/blood.V110.11.2058.2058
Published: 2007
Journal Articles

In Vivo Labeling of Newly Synthesized DNA Suggests That the CD38 + Fraction Is Enriched in Proliferating Cells within a Clone of Chronic Lymphocytic Leukemia B Cells.

Carlo Calissano, MD, Rajendra Damle, PhD, Taraneh Banapour, BS, Denise Cesar, Marc Hellerstein, MD, PhD, Steven Allen, MD, Kanti Rai, MD, Nicholas Chiorazzi, MD
Journal: Blood
Blood (2006) 108 (11): 27.
https://doi.org/10.1182/blood.V108.11.27.27
Published: 2006